The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety

European Journal of Neuroscience

Volumn 16, Issue 7, 2002, Pages 1395-1398

  Haller, J ^a   Bakos, N ^a   Szirmay, M ^a   Ledent, C ^b   Freund, T F ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cannabinoids; Knock out; Plus maze; Receptors

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; KNOCKOUT MOUSE; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; STRAIN DIFFERENCE; WILD TYPE;

EID: 0036431691     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2002.02192.x     Document Type: Article

References (26)

1. Akinshola, B.E., Chakrabarti, A. & Onaivi, E.S. (1999) In-vitro and in-vivo action of cannabinoids. Neurochem. Res., 24, 1233-1240.
2. Arevalo, C., de Miguel, R. & Hernandez-Tristan, R. (2001) Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol. Biochem. Behav., 70, 123-131.
3. Breivogel, C.S., Griffin, G., Di Marzo, V. & Martin, B.R. (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155-163.
4. Capanna, E., Corti, M., Mainardi, D., Parmigiani, S. & Brain. P.F. (1984) Karyotype and intermale aggression in wild house mice: Ecology and speciation. Behav. Genet, 14, 195-208.
5. Compton, D.R., Aceto, M.D., Lowe, J. & Martin, B.R. (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther., 277, 586-594.
6. Crawley, J.N., Corwin, R.L., Robinson, J.K., Felder, C.C., Devane, W.A. & Axelrod, J. (1993) Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav., 46, 967-972.
7. Di Marzo, V., Breivogel, C.S., Tao, Q., Bridgen, D.T., Razdan, R.K., Zimmer, A.M., Zimmer, A. & Martin, B.R. (2000) Levels, metabolism, and pharmacological activity of anandamide in CB (1) cannabinoid receptor knockout mice: Evidence for non-CB (1), non-CB (2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem., 75, 2434-2444.
8. Fabre, L.F. & McLendon, D. (1981) The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. J. Clin. Pharmacol., 21 (Suppl.), 377S-382S.
9. Ferrari, P.F., Palanza, P., Parmigiani, S. & Rodgers, R.J. (1998) Interindividual variability in Swiss male mice: Relationship between social factors, aggression, and anxiety. Physiol. Behav., 63, 821-827.
10. Giuliani, D., Ferrari, F. & Ottani, A. (2000) The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress. Pharmacol. Res., 41, 47-53.
11. Hájos, N., Ledent, C. & Freund, T.F. (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience, 106, 1-4.
12. Haller, J., Makara, G.B. & Kovács, J.L. (1996) The effect of α2 adrenoceptor blockers on aggressive behavior in mice: Implications for the actions of adrenoceptor agents. Psychopharmacology, 126, 345-350.
13. Hilakivi, L.A., Ota, M. & Lister, R.G. (1989) Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral 'despair'. Pharmacol. Biochem. Behav., 33, 371-374.
14. Hogg, S. (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav., 54, 21-30.
15. Jarai, Z., Wagner, J.A., Varga, K., Lake, K.D., Compton, D.R., Martin, B.R., Zimmer, A.M., Bonner, T.I., Buckley, N.E., Mezey, E., Razdan, R.K., Zimmer, A. & Kunos, G. (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. USA, 96, 14136-14141.
16. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W. & Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401-404.
17. Martin, M., Ledent, C., Parmentier, M., Maldonado, R. & Valverde, O. (2002) Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology, 159, 379-387.
18. Navarro, M., Hernandez, E., Munoz, R.M., del Arco, I., Villanua, M.A., Carrera, M.R. & RodrigueZ. de Fonseca, F. (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport, 8, 491-496.
19. Onaivi, E.S., Green, M.R. & Martin, B.R. (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J. Pharmacol. Exp. Ther., 253, 1002-1009.
20. Porter, A.C. & Felder, C.C. (2001) The endocannabinoid nervous system: Unique opportunities for therapeutic intervention. Pharmacol. Ther., 90, 45-60.
21. Poshivalov, V.P. (1980) The integrity of the social hierarchy in mice following administration of psychotropic drugs. Br. J. Pharmacol., 70, 367-373.
22. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Alonso, R., Shire, D., Congy, C., Soubrie, P., Breliere, J.C. & Le Fur, G. (1995) Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci., 56, 1941-1947.
23. Rodgers, R.J. & Cole, J.C. (1993) Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice. Physiol. Behav., 54, 729-736.
24. Sethi, B.B., Trivedi, J.K., Kumar, P., Gulati, A., Agarwal, A.K. & Sethi, N. (1986) Antianxiety effect of cannabis: Involvement of central benzodiazepine receptors. Biol. Psychiatry, 21, 3-10.
25. Tunving, K. (1987) Psychiatric aspects of cannabis use in adolescents and young adults. Pediatrician, 14, 83-91.
26. Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M. & Bonner, T.I. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA, 96, 5780-5785.